Michael L. Goris
Academic Appointments
- Emeritus Faculty, Acad Council, Radiology - Nuclear Medicine
- Member, Stanford Cancer Institute
Key Documents
Contact Information
- Academic Offices
Personal Information Email
Professional Overview
Administrative Appointments
- Chairman, University panel on Radiation safety (2003 - 2010)
Scientific Focus
Current Research Interests
Radio-immunotherapy.
Medical Imaging Processing.
Quantification for diagnosis
Clinical validations
Clinical Trials
- Recruiting Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis
- Recruiting Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
- Not Recruiting Radioactive Iodide (131I) Treatment of 124I PET/CT Detected Breast Cancers
- Not Recruiting S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma
- Not Recruiting Rituximab, Combination Chemotherapy, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma
Publications
- Safety of Repeated Yttrium-90 Radioembolization. Cardiovasc Intervent Radiol. 2013
- Brain uptake of Tc99m-HMPAO correlates with clinical response to the novel redox modulating agent EPI-743 in patients with mitochondrial disease. Mol Genet Metab. 2012; (4): 690-9
- Positron emission tomography of 64Cu-DOTA-Rituximab in a transgenic mouse model expressing human CD20 for clinical translation to image NHL. Mol Imaging Biol. 2012; (5): 608-16
- Pilot pharmacokinetic and dosimetric studies of (18)F-FPPRGD2: a PET radiopharmaceutical agent for imaging α(v)β(3) integrin levels. Radiology. 2011; (1): 182-91
- Targeted systemic radiotherapy with scVEGF/177Lu leads to sustained disruption of the tumor vasculature and intratumoral apoptosis. J Nucl Med. 2011; (10): 1630-7
- 131I-Tositumomab (Bexxar) vs. 90Y-Ibritumomab (Zevalin) therapy of low-grade refractory/relapsed non-Hodgkin lymphoma. Mol Imaging Biol. 2010; (2): 198-203
Help